---
$id: https://graph.org.ai/products/commodity/51142507
$type: Product
source: UNSPSC
code: "51142507"
title: "Pergolide"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pergolide

**UNSPSC Code**: 51142507
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 24MJ822NZ9. European Medicines Agency schedules Pergolide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09725MIG. Pergolide generally arises in the molecular formula C19H26N2S. The term PERGOLIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) PERGOLIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pergolide under HS 29396900 and SITC 54146. As of Q4 2014, PERGOLIDE remains the US FDA Preferred Term for this commodity. Pergolide bears US NLM identifiers UMLS ID C0031007 and NCI Concept Code C61886. SMILES: S(CC1CC2C(N(C1)CCC)CC1C3C2CCCC3[NH]C1)C.

